Spirox logo

Spirox

Spirox is a technology company.

Active
Website LinkedIn
Updated: ·

About

Spirox develops medical devices, focusing on solutions for nasal obstruction. The company’s primary product is the LATERA Absorbable Nasal Implant, designed to treat nasal-valve collapse. This minimally invasive implant supports the lateral nasal wall, aiming to improve airflow and breathing for individuals experiencing chronic nasal blockage. The technology offers a discreet and effective option for patients seeking relief from this common condition.

The company was founded in 2013 by Donald A. Gonzales, a distinguished Otolaryngologist. Dr. Gonzales identified a significant need for a dedicated and less invasive medical device to address the prevalent issue of nasal-valve collapse, drawing upon his clinical expertise to conceptualize a targeted solution that could be effectively deployed to improve patient outcomes.

Spirox’s LATERA implant primarily serves patients diagnosed with nasal obstruction due to structural weakness in the nasal valve. The company's vision centers on enhancing the quality of life for these individuals by providing an innovative, evidence-based treatment. By focusing on a specific, impactful medical need, Spirox aims to offer a durable and patient-friendly alternative to traditional surgical interventions.

Financial History

Spirox has raised $64.0M across 2 funding rounds.

Total Raised
$64.0M
Valuation
N/A

Frequently Asked Questions

How much funding has Spirox raised?

Spirox has raised $64.0M in total across 2 funding rounds.